AGEN

MKT CAP:$145M

Agenus Inc

Market Cap

$145M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$3.23+$0.00 (+0.00%)

Jun 5, 2026

52W High $7.0652W Low $2.77

Company Details

Agenus Inc., a clinical-stage biotechnology company, discovers and develops immunotherapies for cancer and infectious diseases in the United States and internationally. It offers Retrocyte Display, an antibody expression platform for the id...

CEO

—

IPO Date

Feb 4, 2000

Website

www.agenusbio.com

Key Metrics TTM

Revenue

$124M

+24.5% YoY

Net Income

$65M

EPS (Diluted)

Free Cash Flow

-$88M

Revenue / Share

$3.24

Gross Margin

52.1%

Operating Margin

6.6%

Net Margin

52.2%

FCF Margin

-70.7%

P/S

1.2x

P/E

2.2x

Earnings Reports

Q1 2026

May 11, 2026

$34M+40.2%

FY 2025

Mar 16, 2026

$114M+10.4%

Q4 2025

Mar 16, 2026

$34M+27.5%

Q3 2025

Nov 10, 2025

$30M+20.4%

Q2 2025

Aug 11, 2025

$26M+9.3%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee